06.12.2022 - WALTHAM, Mass., Dec. 06, 2022 (GLOBE NEWSWIRE) - Invivyd, Inc. (Nasdaq: IVVD), a clinical-stage biopharmaceutical company on a mission to protect humanity from serious viral respiratory diseases, today announced the appointment of Jeremy Gowler as . Seite 1
23.02.2022 - Achieved 2021 Production of 26,507 BOPD, Up 17% from 2020Total Current Average Production1 of Approximately 30,000 BOPDGenerated 2021 Net Income of $42 Million, Highest Since 20182021 Adjusted EBITDA2 Increased 150% Year-Over-Year to $242 .
Martha SepĂșlveda, who suffers from ALS, will have to wait to learn if she will be the first person in Colombia without a terminal prognosis to die by euthanasia